Cancer Clinical Trial
— OVERSEE-IIOfficial title:
Identification of Potential Improvements in the Acute Care Pathway for Cancer Patients in the Emergency Department (OVERSEE - II Trial)
NCT number | NCT05974800 |
Other study ID # | 10842 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | February 2, 2024 |
Est. completion date | July 1, 2024 |
The goal of this Single center prospective cross-sectional study is to identify the facilitators and barriers among caregivers in the emergency department that influence disposition of patients with solid and hematology malignancies. The main question it aims to answer is to categorize the facilitators and barriers identified by three groups of emergency department (ED) staff. Participants will be asked for permission, afterwards a short interview will be held with the different ED caregivers (ED nurse, attending physician and supervising physician).
Status | Recruiting |
Enrollment | 75 |
Est. completion date | July 1, 2024 |
Est. primary completion date | May 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with solid or hematological malignancies and receiving system therapy or having received systemic therapy within the last 3 months. - Presented at or admitted from the emergency department for the oncology, hematology, neuro- or lung-oncology clinical unit. - Awake and conscious. - Possible to answer questions within the same shift / day after presentation in the ED. Exclusion Criteria: - <18 years old. - Only received a surgical intervention as cancer treatment. - Not willing or able to give written informed consent. |
Country | Name | City | State |
---|---|---|---|
Netherlands | Erasmus MC | Rotterdam | Zuid-Holland |
Lead Sponsor | Collaborator |
---|---|
Erasmus Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Patient characteristics | age, sex, type of cancer, type of treatment, main complaint, triage category, number of prior ED visits. | Through study completion, an average of 6 months | |
Primary | Clusters of facilitator and barriers identified by the emergency department (ED) nurse | (Sub)Clusters of facilitator and barriers identified by the ED nurse for the ED care of patients with cancer | Through study completion, an average of 6 months | |
Primary | Clusters of facilitator and barriers identified by the treating physician | (Sub)Clusters of facilitator and barriers identified by the treating physician for the ED care of patients with cancer | Through study completion, an average of 6 months | |
Primary | Clusters of facilitator and barriers identified by the supervising physician | (Sub)Clusters of facilitator and barriers identified by the supervising physician for the ED care of patients with cancer | Through study completion, an average of 6 months | |
Secondary | Emergency department (ED) length of stay (LOS) | Emergency department length of stay | Through study completion, an average of 6 months | |
Secondary | Disposition | Outcome after ED admission, being home or admission | Through study completion, an average of 6 months | |
Secondary | Correlation between ED-LOS and disposition | Correlation between ED-LOS and disposition | Through study completion, an average of 6 months | |
Secondary | Years of medical experience | Number of years a medical staffmember is working in health care | Through study completion, an average of 6 months | |
Secondary | Need for imaging | Was imaging ordered during ED visit and which kind | Through study completion, an average of 6 months | |
Secondary | ED nurse agreement of disposition | Agreement between ED nurse expected disposition and the actual disposition | Through study completion, an average of 6 months | |
Secondary | Attending physician agreement of disposition | Agreement between treating physician expected disposition and the actual disposition | Through study completion, an average of 6 months | |
Secondary | Supervising physician agreement of disposition | Agreement between supervising physician expected disposition and the actual disposition | Through study completion, an average of 6 months | |
Secondary | Time-to-disposition | The time between patient's arrival at the ED and the decision to disposition | Through study completion, an average of 6 months | |
Secondary | Time-to-ward | The time between the decision to hospitalize and the arrival at the ward | Through study completion, an average of 6 months | |
Secondary | Correlation between time-to-disposition and the ED-LOS | Correlation between time-to-disposition and the ED-LOS | Through study completion, an average of 6 months | |
Secondary | Correlation between time-to-ward and the ED-LOS | Correlation between time-to-ward and the ED-LOS | Through study completion, an average of 6 months | |
Secondary | Difference in categories | The difference in the percentages in categories between the different caregivers | Through study completion, an average of 6 months | |
Secondary | ED nurse summary of actions | Summary of actions taken by ED nurse in the ED care for patients with cancer | Through study completion, an average of 6 months | |
Secondary | Attending physician summary of actions | Summary of actions taken by attending physician in the ED care for patients with cancer | Through study completion, an average of 6 months | |
Secondary | Supervising physician summary of actions | Summary of actions taken by supervising physician in the ED care for patients with cancer | Through study completion, an average of 6 months | |
Secondary | ED crowding | Degree of crowding in the ED, consisting of number of patients in the ED and the ED crowding color code | Through study completion, an average of 6 months | |
Secondary | Difference in clusters per group between day, evening and night | Difference in clusters per ED staff group between day, evening and night | Through study completion, an average of 6 months | |
Secondary | Difference in clusters per group between weekdays and weekend | Difference in clusters per group between weekdays (Monday 08:00 till Friday 16:00) and weekend (Friday 16:01 till Monday 7:59) | Through study completion, an average of 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|